INTRODUCTION
, little is known about their physiological functions. Molecular cloning suggests that the core proteins of most cell surface HSPGs fall into two Heparan sulfate proteoglycans (HSPGs) have been hyfamilies: the syndecan family of transmembrane HSPGs and pothesized to play important roles in nervous system develthe glypican family of glycosylphosphatidylinositol (GPI)opment (Lander, 1993) and have been implicated in such anchored HSPGs. To date, four syndecan family members diverse processes as cell-cell adhesion (Reyes et al., 1990;  have been described (Bernfield et al., 1992) . One member of Stanley et al., 1995) , cell-substratum adhesion (LeBaron et the syndecan family, syndecan-3, is highly expressed in the al., 1988; Haugen et al., 1992) , neurite outgrowth (Wang developing brain (Carey et al., 1992; Gould et al., 1995) . and Denburg, 1992) , and growth factor signaling (Yayon et
The glypican family is currently composed of four mamal., 1991; Kan et al., 1993; Aviezer and Yayon, 1994; Zionmalian proteins: glypican, cerebroglycan, OCI-5, and Kcheck et al., 1995) .
glypican, as well as the product of the Drosophila dally Although several distinct cell surface HSPGs are exgene (Lander et al., 1996) . The amino acid sequences of pressed in the developing nervous system (Herndon and these GPI-anchored HSPGs show considerable homology throughout their length, including an invariant pattern of 14 cysteines that confers upon these molecules a compact, quick-frozen in isopentane on dry ice. Twenty-micrometer cryostat surface heparan sulfate in the developing brain. By in situ sections of all samples were collected on Probe-On Plus slides hybridization, cerebroglycan expression is restricted to the (Fisher) and stored at 080ЊC. Unfixed tissue sections were postfixed developing nervous system where it is transiently expressed by immersion in 4% paraformaldehyde in PBS for 10 min at room in regions containing newly postmitotic neurons (Stipp et temperature prior to storage. al., 1994) . In contrast, glypican mRNA is expressed in ven-For immunohistochemistry, sections were incubated in blocking tricular zones in the developing rat brain and by many prosolution (2% bovine serum albumin [BSA]; 3% goat serum; 100 jection neurons throughout development and into adult life mM Tris -Cl, pH 7.5; 150 mM NaCl; 0.3% Triton X-100). Sections (Karthikeyan et al., 1992 Litwack et al., 1994) . The were washed in TBS (100 mM Tris, pH 7.5; 150 mM NaCl) and, if mRNAs encoding K-glypican and OCI-5 have also been desections were to be developed with horseradish peroxidase, treated twice for 30 min each in 0.3% H 2 O 2 in methanol and washed again tected at low levels in the developing and adult rodent brain in TBS. Affinity-purified 521-2 antibody, diluted in blocking solu- (Watanabe et al., 1995) , and although their expression pattion, was applied overnight at room temperature at a concentration terns have not been thoroughly characterized to date, Kof 2.5-5 mg/ml. For immunofluorescence, a Cy3-conjugated goat glypican mRNA has been detected in the ventricular zone anti-rabbit antibody (Jackson Immunoresearch) was used at a diluof the developing cerebral cortex (Watanabe et al., 1995) .
tion of 1:100 in blocking solution as a secondary antibody. Sections
The distribution of OCI-5 is currently unknown. (20 mg/ml) prior to dehydration and mounting. Nonspecific staining was defined as staining that occurred in the absence of primary antiserum. Sections were examined on a Zeiss Axiophot micro-
METHODS
scope equipped for brightfield, DIC, and epifluorescence.
Antipeptide Antibodies Proteoglycan Isolation and Radioiodination
The peptide CRPPRPPRPPRRDGL, which corresponds to amino Proteoglycans (PGs) were isolated from detergent extracts of neoacids 521-535 of rat cerebroglycan (Stipp et al., 1994) , was synthenatal rat brain membranes by sequential salt elution from DEAEsized and purified by reverse-phase HPLC (Biopolymers Lab, M.I.T.)
Sephacel (Pharmacia) essentially as described (Herndon and Lander, and coupled to keyhole limpet hemocyanin (KLH) as follows: 20 1990). For radioiodination, PGs were rebound to approximately 50 mg of KLH (Pierce Chemical Co., Rockford, IL) was activated by ml of DEAE-Spectra/Gel (Spectrum) in 3-4 volumes of 0.05 M Tris, reaction with 2 mg sulfo-SMCC (Pierce) at room temperature with pH 8.0, containing 0.5% CHAPS overnight at 4ЊC. The beads were stirring for 30 min. Activated KLH was purified over a Sephadex isolated, washed with 0.05 M Tris, pH 8.0, to remove detergent, G-25 column (Pharmacia) equilibrated in 0.1 M sodium phosphate and transferred to a polypropylene tube with a minimum volume (pH 6.0). Twenty-two milligrams of peptide 521 was dissolved in of buffer. PGs were iodinated with 5 mCi of Na 125 I (NEN Dupont). the same buffer and allowed to react overnight at room temperature Iodinations were initiated with the addition of 4 ml of a 1 mg/ml with the activated KLH. KLH-521 complexes were purified over a solution of chloramine T, allowed to proceed for 3 min at room Sephadex G-25 column. Rabbits were injected intradermally with temperature, and terminated with the addition of 43 ml each of 10 2.5 mg KLH-521 in complete Freund's adjuvant and boosted twice mM sodium metabisulfite and 10 mM KI. Beads were transferred intramuscularly with 2.5 mg KLH-521 in incomplete Freund's adjuto a column, washed with 20 ml of 0.05 M Tris, pH 8.0; 0.5% vant. Antisera were collected and subsequently affinity-purified CHAPS; 150 mM NaCl and eluted with 8 1 50-ml aliquots of 0.05 over peptide 521 coupled to Sulfo-Link (Pierce); the resulting affin-M Tris, pH 8.0; 0.5% CHAPS; 750 mM NaCl. Fractions containing ity-purified antibody was designated 521-2. An anti-glypican antithe peak radioactivity were pooled and brought to 1 mg/ml BSA. body, designated 343-1 and directed against amino acids 343-360
Aliquots were flash frozen on dry ice/ethanol and stored at 080ЊC. of rat glypican, was prepared in a similar fashion (E. D. Litwack et Protein determinations were made prior to the addition of BSA al., in preparation).
using the amido black method essentially as described (Herndon and Lander, 1990) with crystalline BSA as standard, except that proteins were precipitated with 10% trichloroacetic acid (TCA).
Immunohistochemistry
Embryonic Sprague-Dawley rats were removed from timed pregnant females and fixed by overnight immersion in 4% paraformal-
Glycosaminoglycan (GAG) Lyase Digestion,
dehyde in Ca 2/ /Mg 2/ -free Dulbecco's phosphate-buffered saline
SDS -PAGE, and Western Blotting
(PBS) at 4ЊC and subsequently cryoprotected in 15% sucrose in PBS. Date of sperm positivity was considered to be Embryonic Day 1 Digestions with heparitinase, chondroitinase ABC (Seikagaku), or both enzymes were performed on 125 I-labeled PGs as described (E1). Brains from postnatal animals were quickly removed and (Herndon and Lander, 1990) , in the presence of 1 mM EDTA, 1 mg/
containing the full open reading frame of the cerebroglycan cDNA (Stipp et al., 1994) into the multicloning site of the pLNCX retrovi-ml phenylmethylsulfonyl fluoride (PMSF), 25 mg/ml N-ethyl maleiimide (NEM), and 1 mg/ml pepstatin A, in a volume of 30 ml. All ral expression vector (Miller and Rosman, 1989) . C2 cells were transfected with pLNCX-CBGD3 using lipofectamine (Gibco BRL) incubations were carried out at 37ЊC except digestions with heparitinase alone, which were performed at 43ЊC to inhibit any contami-according to the instructions of the manufacturer. Conditioned medium from the transfected C2 cells was used to infect C2 cells nating chondroitinase activity. After 4-6 hr, digestions were terminated by the addition of 7.5 ml 51 SDS sample buffer, heated to treated with 200 ng/ml tunicamycin and 8 mg/ml polybrene, creating stable, virus-producing cell lines. 95ЊC for 10 min, and analyzed by SDS-PAGE. For Western blotting, neonatal brain membranes were subjected to GAG lyase digestion PC12 cells were grown in RPMI 1640 with 10% heat-inactivated horse serum, 5% fetal calf serum, glutamine, and penicillin/strepto-in the presence of protease inhibitors, resolved by SDS-PAGE, and electrophoretically transferred to Immobilon P. To block nonspe-mycin on Vitrogen (Celltrix)-coated plates. Cells expressing cerebroglycan were generated by infecting PC12 cells with conditioned cific protein binding, the membrane was incubated in TBS containing 3% goat serum, 2% BSA, and 0.3% Tween 20 for 30 -60 medium, containing 8 mg/ml polybrene, from C2 producer cell lines. Infected PC12 cells were selected by growth in 1 mg/ml G418 min, followed by incubation overnight in the same buffer containing 2.5 mg/ml 521-2 antibody. Incubation with enhanced chemi-and maintained as an uncloned population by growth in 0.5 mg/ ml G418; the cells were designated PC12inf uCBGD3. For immuno-luminescence reagents was performed according to the instructions of the manufacturer (Amersham, Arlington Heights, IL).
histochemistry, PC12inf uCBGD3 cells were grown on laminincoated coverslips (20 mg/ml). Cells were rinsed once in prewarmed RPMI and then fixed for 10 min at room temperature in 4% para-Immunoprecipitation formaldehyde, 5% sucrose in PBS and processed for immunohistochemistry as described above using a Cy3-conjugated second anti-Immunoprecipitations were performed from 125 I-labeled PGs body (Jackson Immunoresearch) at a dilution of 1:100. Coverslips starting with 0.5 1 10 6 TCA-precipitable cpm of material. PGs were were washed in TBS, mounted in Aquamount, and imaged on a subjected to digestion with appropriate GAG lyases, brought to a confocal microscope (MRC-1024) using identical image acquisition volume of 200 ml with the addition of 0.05 M Tris, pH 8.0; 0.5% parameters for both infected and parental control cell lines. CHAPS; 150 mM NaCl (buffer C) containing EDTA and PMSF, and Embryonic Day 18 retinal neurons were cultured using timed cleared by the addition of 30 ml of a 50 mg/ml solution of protein pregnant rats as described (Calof et al., 1994) . Neurons were plated A -Sepharose beads (Sigma) in the same buffer. After rocking for onto merosin (Life Technologies; 40 mg/ml)-coated glass coverslips. 30-60 min at 4ЊC, beads were pelleted by centrifugation and the After 16-20 hr they were fixed and processed for immunofluoressupernatants transferred to fresh tubes. Antibodies were added and cence as described above. the tubes were incubated overnight at 4ЊC with rocking. Immune complexes were collected on protein A -Sepharose for several hours at 4ЊC by the addition of 50 ml protein A -Sepharose. Beads were
RESULTS
collected by centrifugation, washed once with 1 ml buffer C, once with buffer C containing 750 mM NaCl, and again with buffer C. Beads were eluted with 30 ml 21 SDS sample buffer at 95ЊC for 10 Production and Characterization of Antipeptide min and the eluate was analyzed by SDS-PAGE. In some experi-Antibodies ments, samples were washed before elution with 50 mM Tris, pH A synthetic peptide corresponding to amino acids 521-8.0; 150 mM NaCl; 1.0% SDS; 1 mM EDTA, 1 mg/ml PMSF; 25 mg/ ml NEM; and 1 mg/ml pepstatin A. Identical results were obtained. 535 of the cerebroglycan coding sequence was synthesized, coupled to KLH, and used to produce an antiserum in rabbits. The resulting serum, 521-2, was affinity-purified
Growth Cone Particle Preparation
against the same peptide. To confirm the specificity of the affinity-purified antibody, 40 mg of neonatal rat brain memther than was observed with heparitinase digestion alone, consistent with previous observations that cerebroglycan bears only heparan sulfate GAG chains (Herndon and Primary Cell Culture and Establishment of C2 and Lander, 1990) . The poor immunostaining of undigested
PC12 Cell Lines Expressing Cerebroglycan
cerebroglycan (lanes C and U) is most likely due to the poor binding of GAG-bearing PGs to protein blotting membranes A cerebroglycan expression vector, pLNCX-CBGD3, was constructed by subcloning the 1835-bp EagI/NarI restriction fragment (Rapraeger et al., 1985) and not to an inability of the antise-( Fig. 3 ). Highest levels of immunoreactivity were seen in the cerebral cortex, anterior commissure, fornix, optic chiasm, deep layers of the cerebellum, superior and inferior colliculi, and midbrain and brain stem.
Close examination of these and other sections suggests that cerebroglycan is predominantly, if not exclusively, associated with developing axon tracts. For example, in saggital sections through the neocortex at P0 (Fig. 4A ), high levels of cerebroglycan immunoreactivity are seen in the intermediate zone and in fibers that extend from the intermediate zone through the cortical plate toward the pial surface (arrows). This pattern of immunoreactivity corresponds to the pathway by which thalamic axons enter the cortex. These axons grow through turning or sending collaterals that grow upward toward their SDS gel, which was subsequently transferred to Immobilon P, termination zones in the cortical plate (Miller et al., 1993) . of intracortical axons. The ventricular zone, which contains proliferating neural precursors, but very few axons, is devoid of immunoreactivity. In control sections incubated in the absence of the primary antibody, no immunoreactivity is obrum to recognize the intact cerebroglycan molecule, since served ( Fig. 4B ).
521-2 readily immunoprecipitates intact cerebroglycan
Cerebroglycan immunoreactivity can also be seen on fifrom a complex mixture of proteoglycans (see below).
ber bundles coursing within the superficial layers of the To prove the specificity of the antibody, PC12 cells, superior colliculus at P0; these presumably correspond to which do not express any endogenous cerebroglycan (M. E. the axons of retinal ganglion cells invading the stratum Herndon, C. S. Stipp, and A. D. Lander, unpublished obseropticum ( Fig. 4C ), although afferents arising from the cerevations), were infected with a replication-defective retrovibral cortex also project to this region. In intermediate layers rus engineered to direct expression of a full-length cerebroof the superior colliculus, fibers cut in cross section stain glycan cDNA. Infected cells stained strongly with the 521prominently. Based on their position and orientation, these 2 antibody ( Fig. 2A ) in a distinctly punctate pattern similar fibers are likely to be tectobulbar axons ( Fig. 4C ) which run to that seen for other cell-surface GPI-anchored proteins as tightly fasciculated bundles perpendicular to the ingrow- (Sargiacomo et al., 1993; Lisanti et al., 1994) . In contrast, the ing optic axons (Kroger and Walter, 1991) . Cerebroglycan uninfected parental PC12 cell line showed only background immunoreactivity can also be seen on presumptive corticolevels of immunoreactivity ( Fig. 2B) .
tectal fibers in the deep layers of the superior colliculus ( Fig. 4C ). These are likely to correspond to inputs from cortical visual areas, but could also represent descending projec-
Cerebroglycan Expression in the Developing
tions from the superior colliculus to the reticular formation,
Rat Brain
pontine nucleii, inferior olive, or spinal cord (Altman and Bayer, 1981b) . However, since those descending fibers arise In situ hybridization has suggested that cerebroglycan mRNA is restricted to the developing nervous system and, from cell bodies dispersed throughout all collicular layers, and little cerebroglycan mRNA has been observed in the furthermore, that the onset of cerebroglycan gene expression in different parts of the nervous system correlates with superior colliculus at this age ( Fig. 6I of Stipp et al., 1994) , the cerebroglycan-immunoreactive fibers most likely corre-the terminal mitoses of neurons (Stipp et al., 1994) . In extracts of whole rat brain, cerebroglycan protein expression spond to corticotectal afferents. Cerebroglycan immunoreactivity is also seen in the hip-peaks near the day of birth (Herndon and Lander, 1990) . To determine the localization of cerebroglycan in the devel-pocampal formation of the neonatal rat brain. In the coronal section shown in Fig. 4D , immunoreactivity is seen within oping nervous system, we immunostained cryostat sections of rat brain at several developmental ages, concentrating on the stratum radiatum, where both intrahippocampal commissural axons as well as the axons of the Schaffer collateral P0. In parasaggital sections of P0 rat heads, cerebroglycan immunoreactivity was restricted to the nervous system pathway from the hippocampal pyramidal neurons project. Weak immunoreactivity is also seen in the mossy fiber ity can also be seen in a cell layer beneath the external granule layer, corresponding to the developing Purkinje cell layer, the site of axons that arise from granule neurons within the dentate gyrus and project toward area CA3. In layer. Immunoreactivity in this layer appears stronger in dorsal than in ventral cerebellum, a difference that corre-the same section, prominent cerebroglycan immunoreactivity can be seen within several other axon pathways, includ-lates with the maturational gradient of Purkinje cell development. In dorsal regions of the rat cerebellum, Purkinje ing the optic tract, the fimbria of the fornix, the intermediate zone of the cerebral cortex, the corpus callosum, and cells are still migrating into the Purkinje cell layer as late as Embryonic Day 22, but have completed their migrations the internal capsule (not shown). Other major axon tracts that stain strongly for cerebroglycan include the anterior several days earlier in the more posterior and ventral cerebellum (Altman and Bayer, 1985b) . Thus, in the cerebellum commissure (Fig. 3) , the posterior commissure (Fig. 4E) , and spinal commissural axons (see below, Fig. 5 ).
as in the inferior colliculus, the strongest immunoreactivity is associated with the least mature postmitotic neurons.
In the olfactory bulb (Fig. 4H) , weak cerebroglycan staining
The Timing of Cerebroglycan Expression
can be seen in the olfactory nerve layer, which contains the
Correlates with Stages of Cell Migration
intermingled axons of olfactory receptor neurons at various and Early Axon Growth stages of maturity (Shipley and Ennis, 1996) . Intense cerebroglycan immunoreactivity is seen, however, in the rostral mi-In many regions of the developing brain, regional variagratory stream of newly born interneurons which originate in tions in cerebroglycan immunoreactivity correlate with difthe anterior subventricular zone and subsequently migrate into ferences in the developmental stages of neurons. For examthe olfactory bulb. Immunoreactivity is also apparent on the ple, in the inferior colliculus the highest levels of cerebropresumptive axons of mitral cells in the internal plexiform glycan immunoreactivity are seen in the most caudal and layer. In older animals, at P21, specific cerebroglycan immuno-ventral regions (Fig. 4F) , where the most recently postmireactivity is still visible throughout the granular layer of the totic neurons are located (Altman and Bayer, 1981a) . These bulb, consistent with observations that granular neurons con-are also the regions that hybridize most strongly for cerebrotinue to be generated throughout the life of the rat (Kaplan glycan mRNA at this stage (Stipp et al., 1994) . In the P0 and Hinds, 1977), as well as on axons within the lateral olfac-cerebellum (Fig. 4G) , the heaviest labeling is seen in the tory tract (not shown) which presumably correspond to the deep layers in a pattern that correlates with the migratory axons of mitral cells (see Discussion). paths taken by neurons settling into the deep cerebellar nucleii (Altman and Bayer, 1985a) . Weaker immunoreactiv-
In the spinal cord, where neurogenesis is completed earlier than in most parts of the central nervous system (Altman lateral, and ventral funiculi. Immunoreactivity observed in the dorsal funiculus correlates well with the growth of supraseg-and Bayer, 1984) , cerebroglycan mRNA appears before E12 and disappears by E19 (Stipp et al., 1994) . Figure 5 shows the local-mental ascending collaterals of spinal sensory neurons within the developing propriospinal tract (Mirnics and Koerber, 1995) . ization of cerebroglycan immunoreactivity in the E14 and E18 spinal cord. At E14 (Fig. 5A) , intense staining is seen on the Many of these ascending fibers originating in the caudalmost regions of the spinal cord do not reach their targets in the axons of spinal commissural neurons approaching and crossing the floorplate, on motor axons leaving the ventral cord in the hindbrain until P0. Immunoreactivity seen in the lateral and ventral funiculi is most likely due to descending motor axons ventral motor roots, and on axons within both the central and the peripheral roots of sensory neurons of the dorsal root of the reticulospinal and rubrospinal tracts. Axons of each of these tracts have begun to penetrate the spinal cord by E16 ganglia, especially as they enter the spinal cord in the dorsal root entry zones. Immunoreactivity is not seen in the ventricu-and have reached mid-to lower thoracic levels by E18 (Lakke and Marani, 1991; Kudo et al., 1993) . lar zone of the spinal cord nor in the notocord. Thus, cerebroglycan is expressed on every major axon tract in the E14 spinal cord. A similar pattern of staining, albeit less intense, was also
Cerebroglycan Is Polarized to Axons in the Hilar
observed in the E12 spinal cord.
Region of the Hippocampal Dentate Gyrus
In contrast, by E18, the pattern of cerebroglycan immunoreactivity has changed dramatically (Fig. 5B) , and no longer in-Although cerebroglycan immunoreactivity is especially intense in developing fiber tracts, it does not necessarily cludes the axon pathways of primary motor neurons which have largely reached their targets by this stage (Altman and follow that cerebroglycan is expressed more highly on axons than on other parts of the neuron. Because the density of Bayer, 1984) . Instead, immunoreactivity is seen in the dorsal, 
plasma membrane in axon bundles is much higher than in
To circumvent these problems, we turned to the P21 hippocampus. This stage is long after the generation of most regions of neuronal cell bodies, immunostaining for proteins that are evenly distributed on neuronal plasma mem-neurons and, accordingly, cerebroglycan expression in the brain as a whole is extremely low. In the hippocampus, branes can often appear much stronger on fiber tracts than around cell bodies (Morris and Grosveld, 1989) . Levels of however, production of new granule neurons continues in the dentate gyrus throughout life, albeit at a low level staining of dendritic fields should, in principle, be more comparable with that of axon bundles. However, because (Kaplan and Hinds, 1977; Bayer, 1980; Altman and Bayer, 1990a,b) , so one might expect to see small numbers of hip-cerebroglycan is ubiquitously expressed in the developing nervous system, it is difficult to assess levels of dendritic pocampal granule neurons expressing cerebroglycan even in adult animals. Conveniently, the axons and dendrites of staining, since it is difficult to find fields of dendrites that are not intermixed with potentially cerebroglycan-positive dentate granule neurons extend from a compact layer of neuronal cell bodies and grow in opposite directions, with axons.
FIG. 4.
Immunohistochemical localization of cerebroglycan within the developing rat brain. Frozen sections of P0 rat brain were cut at 20 mm in the saggital plane except in D which is a coronal section. In each panel, rostral is to the left. All sections were counterstained with methyl green and photographed under brightfield illumination except E which was photographed using differential interference contrast microscopy. (A) The intermediate zone (iz) of the developing neocortex stains strongly for cerebroglycan as does the marginal zone (mz). Staining can also be seen on fibers extending through the cortical plate (cp). No staining is seen in the ventricular zone (vz). (B) A section through neocortex similar to A except that the primary antibody was omitted. (C) In the superior colliculus, cerebroglycan immunoreactivity is seen on optic axons within the stratum opticum (so), on tectobulbar (tb) axons seen in cross section in central tectal regions, and on corticotectal afferents (ct) in the deep tectal layers. (D) In the hippocampus, weak cerebroglycan immunoreactivity is seen in the mossy fiber layer in the hilar region of the dentate gyrus (dg), extending throughout the stratum radiatum (sr). Strong immunoreactivity is visible in the fimbria of the fornix (ff), as well as in the optic tract (ot) in the dorsal thalamus. (E) Large fascicles of axons within the posterior commissure stain strongly for cerebroglycan. (F) Within the caudal inferior colliculus, cerebroglycan immunoreactivity is widespread, absent only from the ventricular zone (vz). (G) In the cerebellum, strong immunoreactivity is seen throughout the deep cerebellar layers. Cerebroglycan is also seen in the Purkinje cell layer (pcl), where immunoreactivity is seen in dorsal, but not ventral regions. (H) In the olfactory bulb, the strongest cerebroglycan immunoreactivity is seen in the inner plexiform layer (ipl), presumably associated with mitral cell axons, as well as on presumptive granule neurons (gr) within the rostral migratory stream (rms). Weak immunoreactivity is also seen within the olfactory nerve (onl) and glomerular layers (gl). Bar in all panels, 100 mm except D (bar, 200 mm) and E (bar, 25 mm). a single axon heading basally into the hilar region (to join other mossy fibers) and a single dendrite heading apically (Bayer, 1980; Gaarskjaer, 1986) . Thus, at P21 it should be possible to individually examine cerebroglycan expression on well-separated axons, cell bodies, and dendrites of small numbers of granule neurons, without interfering immunostaining from any other cell type.
As shown in Fig. 6 , this was indeed the case. In sections of the P21 hippocampus, small numbers of thin cerebroglycanimmunoreactive fibers were scattered throughout the hilar region; these fibers had the appearance of individual axons. In contrast, little if any cerebroglycan immunoreactivity was detected among the granule cell bodies nor among the layer containing their dendrites. These data demonstrate that, at least for some neurons, cerebroglycan is restricted to the axonal compartment and suggest that this polarized expression pattern may be a general feature of cerebroglycan expression.
Cerebroglycan Is Expressed on Neuronal Growth Cones
The strong localization of cerebroglycan to the axons of newly generated neurons raises the possibility that it could function on axonal growth cones. To address whether cerebroglycan is expressed on growth cones in vitro and in vivo, E18 retinal neurons were cultured on merosin-coated glass coverslips for 20 hr and immunostained for cerebroglycan. As can be seen in Fig. 7 , strong cerebroglycan immunoreactivity was observed on growing neurites, including the growth cones. Heavy staining was seen along the leading edge of veil-rich regions (Fig. 7A) , as well as along filopodia, where highly punctate staining ( Figs. 7B and 7C) , consistent with clustering of cerebroglycan in the membrane, was typically observed.
To determine if cerebroglycan is also a prominent component of growth cones in vivo, total proteoglycans were purified from freshly isolated growth cone particles and radioiodinated, and their core proteins were analyzed by SDS -PAGE following digestion with specific GAG lyases (Fig.  8A) . Three major HSPGs were seen in these preparations, with apparent core protein molecular weights of approximately 135, 60, and 54 kDa, corresponding to syndecan 3, glypican, and cerebroglycan (formerly known as HSPGs M7, M12, and M13, respectively; Herndon and Lander, 1990) . Identical results were obtained in five independent preparations. The identification of the 60-and 54-kDa species as FIG. 6. Cerebroglycan expression in the hilar region of the Postglypican and cerebroglycan, respectively, was based on the natal Day 21 rat hippocampus. Saggital sections of fresh-frozen ability of anti-glypican and anti-cerebroglycan antisera to P21 rat brain were cut at 12 mm on a cryostat, postfixed, and specifically immunoprecipitate these molecules (Fig. 8B) . growth cone particles are similar to those in whole-brain Bar, 40 mm. membranes (cf. Herndon and Lander, 1990) , PGs as a whole were enriched in the growth cone fraction. Specifically, in only transiently expressed by growing axons is the lateral olfactory tract, which primarily consists of axons of the growth cones of neonatal rat brain, PGs constituted bemitral cells of the olfactory bulb, but also contains fibers tween 1.21 and 1.69% of total protein (1.43 { 0.24%, n Å that originate in the raphe nuclei and locus coeruleus and 3), whereas in whole-brain membranes they were approxiinnervate the olfactory bulb (Shipley and Ennis, 1996) . mately three times less abundant (0.45% of total protein, n Cerebroglycan immunoreactivity was detected in the lat-Å 2). eral olfactory tract as late as P21 (unpublished observations), despite the fact that mitral cells are born between E14 and E16 and raphe and locus coeruleus neu-
DISCUSSION
rons are born by E16 and E14, respectively . Other than this, the only evidence of cerebroglycan To investigate the roles of cell surface HSPGs in neural expression at P21 was associated with regions of very late development, we generated specific antibodies against neurogenesis (dentate granule neurons of the hippocampus cerebroglycan, a GPI-anchored HSPG expressed specifically [Fig. 6] ; granule neurons of the olfactory bulb [not shown]), within the developing nervous system. The antibodies are or regions where small numbers of axons had not yet findirected against an epitope near the C-terminus of the maished growing (e.g., the internal capsule, which contains ture polypeptide and recognize both the core protein and some very late-developing axons of the corticospinal tract the intact HSPG (Figs. 1, 2, and 8) . Immunostaining of the [not shown]). developing rat nervous system indicates that cerebroglycan
In at least one cell type, the hippocampal granule neuron, is highly localized to developing axon tracts and growth expression of cerebroglycan is specifically polarized to the cones. Furthermore, these data indicate that cerebroglycan axonal compartment, as no dendritic or cell-body staining is predominantly, if not exclusively, a product of neurons could be detected (Fig. 6 ). This could reflect either preferen-(rather than glial cells), a result that in situ hybridization tial sorting or preferential stabilization of the cerebroglycan data had suggested (Stipp et al., 1994) .
molecule. In several types of cells, GPI-anchors have been As long as they were examined at stages when axons are shown to target proteins to specific cellular domains, inactively growing, all axon tracts appeared to be immunorecluding the axonal compartment of hippocampal pyramidal active for cerebroglycan, suggesting that cerebroglycan may neurons in vitro (Dotti and Simons, 1990) . Indeed axoninbe a general marker expressed by immature neurons. In 1/TAG-1 is another example of a GPI-anchored glycoprotein most cases, axon tracts became cerebroglycan negative that appears to be preferentially associated with axons within several days after the final mitosis of their neurons (Dodd et al., 1988) . Nevertheless, it cannot be that GPI of origin (cf. Fig. 5) , usually around the time that axons anchorage targets cerebroglycan or other proteins to axons, arrived at their targets. For instance, the axons of spinal since the GPI-anchored glycoprotein Thy-1 is actually exsensory neurons, which reach their central targets between cluded from growing axons in vivo (Xue et al., 1991) . It will E16 and E18 (Mirnics and Koerber, 1995b) , stained strongly be interesting to determine whether particular structural for cerebroglycan at E14, but had largely lost cerebroglycan features in the core protein and/or glycosaminoglycan immunoreactivity by E18.
chains of cerebroglycan play a direct role in controlling the unique localization of this proteoglycan. An apparent exception to the rule that cerebroglycan is on axons from early stages of axon elongation to the time that synaptic contacts are initially made. This corresponds to the time when most of the navigational decisions of axons are being made. That cerebroglycan may play a role in these decisions is supported by the fact that this HSPG is highly localized to axons and, importantly, is expressed on growth cones, the organelles that are directly responsible for axonal responses to guidance cues. Interestingly, it appears that not just cerebroglycan, but all three of the major HSPGs of the developing brain-cerebroglycan, glypican, and syndecan-3-are prominent components of growth cones (cf. Fig. 8 ). In addition, immunoreactivity for both glypican and syndecan-3 (Gould et al., 1995) has been seen on axon tracts. These observations suggest that cell surface HSPGs in general may play an important role in the responses of growth cones to their environment.
Currently, the most accepted model of how cell surface heparan sulfate proteoglycans function is that they act as coreceptors for a variety of secreted and cell-surface ligands. These include growth factors, such as the fibroblast growth sulfate in order to bind to and initiate signaling from their brain growth cone particles by ion-exchange chromatography, rareceptors (Rapraeger et al., 1991; . They dioiodinated, digested with specific GAG lyases, and analyzed by also include extracellular matrix proteins, such as fibronec-SDS-PAGE on a 7.5% nonreducing gel. Lanes are untreated (U), tins, laminins, and thrombospondins (Woods and Couchchondroitinase ABC treated (C), heparitinase treated (H), and diman, 1992). It is noteworthy that many of the molecules in gested with both chondroitinase ABC and heparitinase (CH). Three these categories affect the behavior of growth cones and distinct HSPGs are resolved following digestion with heparitinase, may serve as axon guidance cues in vitro and in vivo (Gomez but not with chondroitinase. The core protein of syndecan 3 has and Letourneau, 1994; Kuhn et al., 1995; McFarlane et al., an apparent MW of approximately 135 kDa, glypican has an apparent MW of 60 kDa, and cerebroglycan has an apparent MW of 1995). Whether cerebroglycan, or any other HSPG, is inapproximately 54 kDa. (B) Immunoprecipitation of glypican and volved in growth cone responses to these molecules remains cerebroglycan from radioiodinated growth cone proteoglycans. Imto be seen. However, it has been shown in some systems munoprecipitations were performed with anti-glypican (antibody that removal of heparan sulfate (Wang and Denburg, 1992) , 343-1) and anti-cerebroglycan (antibody 521-2) antisera as described or removal of GPI-anchored molecules (Chang et al., 1992) , under Methods, following digestion with GAG lyases as indicated.
can interfere with growth cone guidance in vivo.
Immune complexes were eluted with hot SDS sample buffer and To date, the most definitive data on the function of GPIresolved by SDS -PAGE on a 7.5% nonreducing gel.
anchored HSPGs in the nervous system comes from the study of mutant alleles of the Drosophila dally (division abnormally delayed) gene, which encodes a proteoglycan In a few cases, cerebroglycan staining in the P0 rat brain of the glypican family that is approximately 45% similar was not obviously associated with axon tracts: In the cereto each of the known glypican family members, including bellum, the strongest immunoreactivity was associated cerebroglycan (Lander et al., 1996; Nakato et al., 1995) . In with regions where newly postmitotic neurons (deep cereflies homozygous for hypomorphic dally alleles, the lamina bellar neurons, Purkinje cells) were completing cell migraprecursor cells, which give rise to synaptic target neurons tion (Fig. 4G) . Similarly, in the P0 olfactory bulb, strong for photoreceptor axons, show a delayed entry into mitosis immunoreactivity was associated with the rostral migrain the first of two stereotypic cell divisions. The second cell tory stream, the final stage of the migratory pathway for division, which is triggered by an intercellular signal from several types of olfactory interneurons (Fig. 4H) . It is possithe photoreceptor axons as they arrive in the target region, ble that the immunoreactivity seen in these locations repredoes not occur. Although the mechanism underlying this sents staining of early axonal processes that are extended phenotype has yet to be elucidated, the results are consisby cells as they migrate. More likely, in some neurons, tent with a defect in a growth factor signaling pathway. It cerebroglycan may initially be expressed diffusely, before will be interesting to determine whether the dally protein becoming polarized to axons.
acts as a coreceptor for any known Drosophila growth fac-
Potential Functions of Cerebroglycan
tors and, if so, whether vertebrate homologs of those growth factors also employ members of the glypican family as core-The data presented here indicate that, in most if not all of the central nervous system, cerebroglycan is expressed ceptors.
